PMID- 27162100 OWN - NLM STAT- MEDLINE DCOM- 20170808 LR - 20220318 IS - 1590-3729 (Electronic) IS - 0939-4753 (Linking) VI - 26 IP - 7 DP - 2016 Jul TI - Serum uric acid level and left ventricular hypertrophy in elderly male patients with nonvalvular atrial fibrillation. PG - 575-580 LID - S0939-4753(15)30180-0 [pii] LID - 10.1016/j.numecd.2016.03.011 [doi] AB - BACKGROUND AND AIMS: Recent studies have suggested that serum uric acid (SUA) induces oxidative stress and inflammation, which are involved in the mechanism of cardiac hypertrophy. In patients with atrial fibrillation (AF), comorbidity of left ventricular hypertrophy (LVH) exacerbates cardiac function. In this study, we investigated the association between SUA and cardiac hypertrophy in AF patients. METHODS AND RESULTS: Initially, 1296 consecutive elderly patients (age >60) with nonvalvular AF were retrospectively selected from the inpatient clinic between January 2012 and April 2015. Demographic, clinical, and echocardiographic characteristics were carefully recorded. The final study population was 577 patients. The mean SUA level was significantly higher in patients with LVH than those without LVH. Compared with the non-LVH group, the LVH group was older, had a higher percentage of female patients, and had lower hemoglobin levels and estimated glomerular filtration rates. Patients in the LVH group also had a higher rate of coronary heart disease and fewer had history of radiofrequency ablation compared with the non-LVH group. In the hyperuricemia group, B-type natriuretic peptide levels, left atrial diameter, left ventricular mass index, and percentage of NYHA (New York Heart Association) class III/IV were significantly higher than the SUA normal group. Multivariate logistic regression analysis indicated the independent risk factors for LVH in elderly AF patients included SUA, age, male sex, the presence of coronary heart disease, and diuretic therapy. Subgroup analysis identified SUA as a significant risk factor associated with LVH in men. CONCLUSIONS: SUA was independently associated with LVH in elderly male patients with nonvalvular AF. CI - Copyright (c) 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved. FAU - Liang, W Y AU - Liang WY AD - Department of Geriatrics, Peking University First Hospital, Beijing, People's Republic of China. FAU - Liu, W W AU - Liu WW AD - Department of Geriatrics, Peking University First Hospital, Beijing, People's Republic of China. FAU - Liu, M L AU - Liu ML AD - Department of Geriatrics, Peking University First Hospital, Beijing, People's Republic of China. Electronic address: meilinliu@yahoo.com. FAU - Xiang, W AU - Xiang W AD - Department of Geriatrics, Peking University First Hospital, Beijing, People's Republic of China. FAU - Feng, X R AU - Feng XR AD - Department of Geriatrics, Peking University First Hospital, Beijing, People's Republic of China. FAU - Huang, B AU - Huang B AD - Department of Geriatrics, Peking University First Hospital, Beijing, People's Republic of China. FAU - Chen, X H AU - Chen XH AD - Department of Geriatrics, Peking University First Hospital, Beijing, People's Republic of China. FAU - Sun, Y S AU - Sun YS AD - Department of Geriatrics, Peking University First Hospital, Beijing, People's Republic of China. LA - eng PT - Journal Article PT - Observational Study PT - Research Support, Non-U.S. Gov't DEP - 20160331 PL - Netherlands TA - Nutr Metab Cardiovasc Dis JT - Nutrition, metabolism, and cardiovascular diseases : NMCD JID - 9111474 RN - 0 (Biomarkers) RN - 268B43MJ25 (Uric Acid) SB - IM MH - Age Factors MH - Aged MH - Aged, 80 and over MH - Atrial Fibrillation/*complications/diagnosis MH - Biomarkers/blood MH - Chi-Square Distribution MH - Humans MH - Hypertrophy, Left Ventricular/diagnostic imaging/*etiology/physiopathology MH - Hyperuricemia/blood/diagnosis/*etiology MH - Logistic Models MH - Male MH - Multivariate Analysis MH - Retrospective Studies MH - Risk Factors MH - Sex Factors MH - Up-Regulation MH - Uric Acid/*blood MH - *Ventricular Function, Left MH - *Ventricular Remodeling OTO - NOTNLM OT - Atrial fibrillation OT - Left ventricular hypertrophy OT - Serum uric acid EDAT- 2016/05/11 06:00 MHDA- 2017/08/09 06:00 CRDT- 2016/05/11 06:00 PHST- 2015/08/24 00:00 [received] PHST- 2016/03/10 00:00 [revised] PHST- 2016/03/15 00:00 [accepted] PHST- 2016/05/11 06:00 [entrez] PHST- 2016/05/11 06:00 [pubmed] PHST- 2017/08/09 06:00 [medline] AID - S0939-4753(15)30180-0 [pii] AID - 10.1016/j.numecd.2016.03.011 [doi] PST - ppublish SO - Nutr Metab Cardiovasc Dis. 2016 Jul;26(7):575-580. doi: 10.1016/j.numecd.2016.03.011. Epub 2016 Mar 31.